Literature DB >> 4272455

Action of eledoisin on human lacrimal secretion in normal and pathological conditions.

M Impicciatore, G Maraini, G Bertaccini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4272455     DOI： 10.1007/bf00503978

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  6 in total

1.  The isolation and amino acid sequence of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone.

Authors:  A ANASTASI; V ERSPAMER
Journal:  Arch Biochem Biophys       Date:  1963-04       Impact factor: 4.013

2.  The treatment of sjoegren's syndrome with physalaemin.

Authors:  G De Caro; M Cordella; P Miani
Journal:  Ophthalmologica       Date:  1969       Impact factor: 3.250

3.  [Effect of physalaemine on lacrimal and salivary secretion in Sjögren's syndrome].

Authors:  G Sala; M Cortellaro; C B Ballabio
Journal:  Reumatismo       Date:  1968 Sep-Oct

4.  Effects of physalaemin on some exocrine secretions of dogs and rats.

Authors:  G Bertaccini; G de Caro; M Impicciatore
Journal:  J Physiol       Date:  1967-12       Impact factor: 5.182

5.  Occurrence of physalaemin in extracts of the skin of Physalaemus fuscumaculatus and its pharmacological actions on extravascular smooth muscle.

Authors:  G Bertaccini; J M Cei; V Erspamer
Journal:  Br J Pharmacol Chemother       Date:  1965-10

6.  The action of eledoisin on the systemic arterial blood pressure of some experimental animals.

Authors:  V Erspamer; A Glaesser
Journal:  Br J Pharmacol Chemother       Date:  1963-06
  6 in total
  1 in total

1.  Effect of eledoisin on tear volume and tear flow in humans as assessed by fluorophotometry.

Authors:  M Göbbels; J Selbach; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.